Document Detail

Recent progress in the metabolic engineering of alkaloids in plant systems.
MedLine Citation:
PMID:  22954587     Owner:  NLM     Status:  MEDLINE    
Plant alkaloids have a rich chemical ecology that has been exploited for medicinal purposes for thousands of years. Despite being highly represented within today's pharmacopoeia, relatively little is known about the biosynthesis, regulation and transport of these molecules. Understanding how nature synthesizes plant alkaloids will enhance our ability to overproduce--that is, to metabolically engineer--these medicinally useful compounds as well as new-to-nature compounds (with potentially improved bioactivity) derived from these natural scaffolds. Recent progress in the metabolic engineering of nitrogen-containing plant natural products--specifically the monoterpene indole alkaloids, the benzylisoquinoline alkaloids and the glucosinolates--was made possible through the characterization of various components in both native and engineered enzymatic pathways. The subsequent reconfiguration and tuning of these biological 'parts' has enabled the production of selected products at increasingly higher titers.
Weslee S Glenn; Weerawat Runguphan; Sarah E O'Connor
Related Documents :
24304517 - Physiological differences explain the co-existence of different regeneration strategies...
23748087 - Utilization of pentoses from sugarcane biomass: techno-economics of biogas vs. butanol ...
24393387 - Bet hedging in desert winter annual plants: optimal germination strategies in a variabl...
19496427 - Isolation of entomopathogenic fungi from soils and ixodes scapularis (acari: ixodidae) ...
17994287 - Fungi and macroaggregation in deep-sea sediments.
23089357 - Hexachlorobenzene dechlorination in constructed wetland mesocosms.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review     Date:  2012-09-03
Journal Detail:
Title:  Current opinion in biotechnology     Volume:  24     ISSN:  1879-0429     ISO Abbreviation:  Curr. Opin. Biotechnol.     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-03-18     Completed Date:  2013-05-17     Revised Date:  2014-04-02    
Medline Journal Info:
Nlm Unique ID:  9100492     Medline TA:  Curr Opin Biotechnol     Country:  England    
Other Details:
Languages:  eng     Pagination:  354-65     Citation Subset:  IM    
Copyright Information:
Copyright © 2012 Elsevier Ltd. All rights reserved.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alkaloids / biosynthesis,  chemistry,  metabolism*
Benzylisoquinolines / chemistry,  metabolism
Biological Products / chemistry,  metabolism
Cytochrome P-450 Enzyme System / metabolism
Glucosinolates / chemistry,  metabolism
Indole Alkaloids / chemistry,  metabolism
Metabolic Engineering*
Monoterpenes / chemistry,  metabolism
Plants / genetics*,  metabolism*
Grant Support
BB/J004561/1//Biotechnology and Biological Sciences Research Council; GM074820/GM/NIGMS NIH HHS; R01 GM074820/GM/NIGMS NIH HHS
Reg. No./Substance:
0/Alkaloids; 0/Benzylisoquinolines; 0/Biological Products; 0/Glucosinolates; 0/Indole Alkaloids; 0/Monoterpenes; 9035-51-2/Cytochrome P-450 Enzyme System

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  High-resolution fish on DNA fibers for low-copy repeats genome architecture studies.
Next Document:  Impacts of normal aging on different working memory tasks: Implications from an fMRI study.